Avalon GloboCare Corp.
ALBT
NASDAQ
| Weiss Ratings | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.79 | |||
| Price History | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 8.39% | |||
| 30-Day Total Return | -10.53% | |||
| 60-Day Total Return | -28.83% | |||
| 90-Day Total Return | -39.63% | |||
| Year to Date Total Return | -40.91% | |||
| 1-Year Total Return | -84.57% | |||
| 2-Year Total Return | -93.97% | |||
| 3-Year Total Return | -96.98% | |||
| 5-Year Total Return | -98.87% | |||
| 52-Week High % Change | -85.94% | |||
| 52-Week Low % Change | 41.67% | |||
| Price | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.42 | |||
| 52-Week Low Price | $0.24 | |||
| 52-Week Low Price (Date) | May 03, 2024 | |||
| 52-Week High Price (Date) | Jun 06, 2023 | |||
| Valuation | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.08M | |||
| Enterprise Value | 31.30M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.53 | |||
| Earnings Per Share Growth | 21.12% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -0.44 | |||
| Price/Book (Q) | -0.24 | |||
| Enterprise Value/Revenue (TTM) | -4.57 | |||
| Price | $0.28 | |||
| Enterprise Value/EBITDA (TTM) | -2.10 | |||
| Enterprise Value/EBIT | -2.07 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 11.00M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 732 780 4400 | |||
| Address | 4400 Route 9 South Freehold, NJ 07728 | |||
| Website | www.avalon-globocare.com | |||
| Country | United States | |||
| Year Founded | 2016 | |||
| Profitability | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 220.63% | |||
| Profit Margin | 234.00% | |||
| Management Effectiveness | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -47.83% | |||
| Return on Equity | -- | |||
| Income Statement | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.26M | |||
| Total Revenue (TTM) | -6.99M | |||
| Revenue Per Share | -$0.64 | |||
| Gross Profit (TTM) | -8.01M | |||
| EBITDA (TTM) | -15.22M | |||
| EBIT (TTM) | -15.43M | |||
| Net Income (TTM) | -16.37M | |||
| Net Income Avl. to Common (TTM) | -16.37M | |||
| Total Revenue Growth (Q YOY) | -2,928.86% | |||
| Earnings Growth (Q YOY) | -295.21% | |||
| EPS Diluted (TTM) | -1.53 | |||
| EPS Diluted Growth (Q YOY) | -254.18% | |||
| Balance Sheet | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 285.40K | |||
| Cash Per Share (Q) | $0.03 | |||
| Total Current Assets (Q) | 850.90K | |||
| Total Preferred Equity (Q) | 20.00 | |||
| Total Equity (Q) | 7.37M | |||
| Current Ratio (Q) | 0.126 | |||
| Book Value Per Share (Q) | -$1.15 | |||
| Total Assets (Q) | 20.58M | |||
| Total Current Liabilities (Q) | 6.76M | |||
| Total Debt (Q) | 8.51M | |||
| Total Liabilities (Q) | 13.21M | |||
| Total Common Equity (Q) | -12.63M | |||
| Cash Flow | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -22.20K | |||
| Cash from Financing (TTM) | 4.83M | |||
| Net Change in Cash (TTM) | -1.71M | |||
| Levered Free Cash Flow (TTM) | -8.01M | |||
| Cash from Operations (TTM) | -6.50M | |||
